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of the corpus callosum (Pfefferbaum et al., 2001; Sullivan and 
Pfefferbaum, 2006).
Because WM is malleable and its bulk reﬂ  ects a dynamic equi-
librium of growth and decline, age differences in the WM structure 
may stem from alteration in mechanisms that are responsible for 
maintaining that equilibrium. One potentially important factor in 
this process is brain-derived neurotrophic factor (BDNF). BDNF is 
a multipurpose protein that plays important roles in many events, 
including neuronal differentiation, proliferation of dendritic 
arbor, synaptic plasticity, and, most notably for the topic of this 
report, axonal sprouting (Egan et al., 2003; Binder and Scharfman, 
2004). In addition, BDNF has metabotropic effects (Lebrun et al., 
2006), and is protective against ischemia (Yanamoto et al., 2004; 
Nomura et al., 2005; Schäbitz et al., 2007; Mochizuki et al., 2008). 
Thus, adequate BDNF activity may be critical for maintaining WM 
integrity.
Brain-derived neurotrophic factor production declines with 
age (Sohrabji and Lewis, 2006) and is reduced by age-depend-
ent vascular risk factors such as hypertension (Lee et al., 2006), 
hypoperfusion (Irikura et al., 1996), and poor glucose metabo-
lism (Krabbe et al., 2007). Although experimental study of BDNF 
effects on brain aging is hampered by impossibility to manipulate 
human BDNF levels in vivo, natural occurring ‘mendelian rand-
omization’ (Katan, 1986) of individuals into groups by BDNF avail-
ability presents an opportunity for an inquiry into BDNF effects. 
These natural groups are determined by a variant in the gene that 
controls BDNF production, BDNF val66met. The low-activity met 
INTRODUCTION
Cerebral white matter (WM) changes throughout the lifespan. Its 
volume increases from childhood to young adulthood, remains 
stable during middle age, and shrinks in senescence (Pfefferbaum 
et al., 1994; Bartzokis, 2004; Hasan et al., 2008; Raz and Kennedy, 
2009). In late adulthood, WM accumulates pathological changes 
(de Leeuw et al., 2001), and the myelin sheath exhibits structural 
defects (Peters, 2002). Deterioration of the WM leads to loss of 
orientation differences in water diffusivity, reﬂ  ected on diffusion 
tensor imaging (DTI) (Pierpaoli and Basser, 1996). DTI studies 
of normal aging show that the microstructural integrity of WM 
is also reduced with age, with a greater difference observed in 
anterior than posterior regions (Pfefferbaum, et al., 2000, 2005; 
O’Sullivan et al., 2001; Sullivan et al., 2001; Head et al., 2004; Salat 
et al., 2005; Sullivan and Pfefferbaum, 2006; Ardekani et al., 2007; 
Kochunov et al., 2007; Madden et al., 2007; Hugenschmidt et al., 
2008; Stadlbauer et al., 2008; Kennedy and Raz, in press). The 
mechanisms of these differences are not entirely understood, but 
are believed to reﬂ  ect cerebrovascular properties of the WM and 
are partly under genetic control. Notably, the regions of the brain 
that are late to myelinate (Flechsig, 1901) may be most vulnerable 
to the effects of normal aging (Bartzokis, 2004; Raz, 2004). Frontal 
regions for example develop relatively late (Sowell et al., 1999) and 
show greater inﬂ  uence of environmental than genetic factors in 
comparison to the posterior regions. Speciﬁ  cally, the proportion 
of genetic to environmental contributions to fractional anisotropy 
(FA) is estimated as 3:1 for the splenium but only 1:1 for the genu 
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allele of that  polymorphism is linked to reduced volume of the hip-
pocampus (Pezawas et al., 2004; Szeszko et al., 2005; Bueller et al., 
2006; Chepenik et al., 2009), parahippocampal (Takahashi et al., 
2008) and prefrontal (Pezawas et al., 2004; Nemoto et al., 2006; 
Takahashi et al., 2008) cortices but not of the amygdala (Sublette 
et al., 2008). Carriers of BDNF 66met also evidence suboptimal 
cognitive performance (e.g., Egan et al., 2003; Bath and Lee, 2006; 
Miyajima et al., 2008; Raz et al., 2009). However, to the best of 
our knowledge, there are no reports of BDNF effects on the WM 
microintegrity in a healthy aging population. In addition, although 
there is evidence of exacerbation of BDNF val66met by vascular 
risk (e.g., Raz et al., 2009), little is known of such conjoint effects 
on brain structure.
In this study we asses the inﬂ  uence of BDNF val66met genotype 
and vascular risk on the microstructural integrity of the genu and 
the splenium of the corpus callosum. In a limited-scale study, the 
densely myelinated corpus callosum (Lamantia and Rakic, 1990) 
is an excellent candidate region to explore effects of genetic factors 
on the WM. Moreover, the genu and the splenium are well suited 
for a comparison as WM microintegrity declines more with age 
in the former than in the latter (Sullivan and Pfefferbaum, 2006; 
Raz and Kennedy, 2009). We hypothesized that older participants 
and individuals with hypertension would evidence reduced FA in 
both regions, and that carriers of the BDNF 66met allele would 
show additional reduction in FA. We also tested for interactive or 
synergistic effects of age, hypertension and reduced BDNF avail-
ability on WM integrity.
MATERIALS AND METHODS
PARTICIPANTS
The participants were screened for history of neurological and psy-
chiatric conditions, head trauma with loss of consciousness, alcohol 
and drug abuse, diabetes, thyroid problems, and cardiovascular 
disease (except controlled essential hypertension). Participants were 
screened for dementia and depression with the MMSE (Folstein 
et al., 1975) and the Center for Epidemiological Study Depression 
Scale (CES-D; Radloff, 1977), with cut-offs of 26 and 15, respec-
tively. All participants were strongly right-handed (75% and above 
on the Edinburgh Handedness Questionnaire; Oldﬁ  eld, 1971). 
Participants provided written informed consent in accord with 
university and hospital review board guidelines.
The sample was part of a larger sample of 77 adult volunteers 
(age 19–84, 49 women) who underwent MRI scanning and cognitive 
testing as described elsewhere (Kennedy and Raz, 2009; Kennedy 
and Raz, in press). Genetic material was available on 41 Caucasian 
participants (all of which are included in this study), 25 women 
and 16 men, 43–81 years old (mean 64.17 ± 10.06 years), and had 
an average education at college level (mean 16.34 ± 2.68 years). Of 
the 25 women, 17 were in the val and 8 were in the met group, and 
of the men, 9 were in the val group, and 7 were in the met group. 
Sample demographic information is presented in Table 1. There 
were no sex differences in age, CES-D or MMSE scores, systolic 
or diastolic blood pressure (all t ≤ 1 ns). Men attained on average 
two more years of formal education than women [t(39) = 2.48, 
p < 0.02]. The sample included 17 individuals with hypertension, 
deﬁ  ned as described below. Only 2 (4.9%) participants smoked 
tobacco products and 30 (73%) reported exercising regularly. Thus, 
the participants of this study were healthier and better educated 
than the general population (American Heart Association, 2004).
GENOMIC ANALYSIS
DNA isolations and genotyping assays were conducted in the Wayne 
State University Applied Genomics Technology Center. For geno-
typing quality control, 10% direct repeats and DNA sequencing 
for veriﬁ  cation were performed. We used both control DNA and 
no-template controls, and ran all 5′-nuclease assays on an Applied 
Biosystems 7900. After isolating DNA from buccal cultures obtained 
in mouthwash samples, we used a Gentra Autopure LS under the 
standard buccal cell protocol.
Polymorphism for BDNF val66met (rs6265) was interrogated 
using Taqman SNP Genotyping assays, with DNA sequencing 
reactions carried out using the 0.5× protocol for ABI PRISM 
BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied 
Biosystems). The sequencing extension products, puriﬁ  ed with 
Sephadex, were analyzed on an ABI PRISM 3700 DNA Analyzer 
using a 50-cm capillary array.
The allelic distribution of the BDNF val66met polymorphism ﬁ  t 
the Hardy–Weinberg equilibrium (χ2 = 2.05, p = 0.15), with 63% of 
participants being val homozygotes (n = 26), and 37% val/met het-
erozygotes (n = 15), whereas no participants had the rare met/met 
genotype. The val/val and the val/met individuals did not differ in 
age (p = 0.86), education level (p = 0.48), MMSE (p = 0.51), CES-D 
(p = 0.17) scores, or systolic (p = 0.22) or diastolic (p = 0.29) blood 
pressure (see Table 1 for sample demographics by genotype).
BLOOD PRESSURE MEASURES
Each participant had systolic and diastolic blood pressure meas-
ured with an analog mercury sphygmomanometer (Model 12–525; 
Country Technology, Gays Mills, WI, USA) equipped with a stand-
ard brachial cuff (Omron Professional). Participants sat in a com-
fortable chair in a climate-controlled ofﬁ  ce. Blood pressure was 
measured on three separate days, once from each arm, and averaged 
Table 1 | Sample demographic information by BDNF genotype and total sample: mean ± SD.
Group  N  Age Edu  MMSE  CES-D  Systolic  BP  Diastolic  BP
val/val 26  63.96  ± 10.79  16.11 ± 2.82  28.35 ± 1.16  3.42 ± 3.59  127 .40 ± 11.93  74.37 ± 8.84
val/met 15 64.53  ± 8.99  16.73 ± 2.46  28.60 ± 1.18  5.33 ± 5.16  132.65 ± 14.57  77 .08 ± 5.52
Total 41  64.17  ± 10.06  16.34 ± 2.68  28.44 ± 1.16  4.12 ± 4.24  129.32 ± 13.03  75.36 ± 7 .83
N, sample size; edu, years of education; MMSE, mini-mental status exam; CES-D, center for epidemiological study depression scale; BP , blood pressure mmHg. The 
groups did not differ signiﬁ  cantly on any of the demographic variables (all p-values > 0.17).Frontiers in Human Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 19  |  3
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FIGURE 1 | Demarcation of the corpus callosum regions of interest 
(ROIs): genu (red) and splenium (blue). The ROIs are displayed on a 
fractional anisotropy map.
across samples and sessions. Current and prior hypertensive status 
and medication information was collected from an interview and 
a comprehensive health questionnaire completed before entrance 
to the study. Only participants who had controlled hypertension 
or were normotensive were allowed into the study. Hypertension 
was operationally deﬁ  ned as systolic blood pressure greater than 
140 mmHg and diastolic pressure greater than 90 mmHg (Joint 
National Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure, 1997). Individuals whose blood 
pressure exceeded the cutoff were referred to their physician.
MRI PROTOCOL
MR images were acquired on a 1.5-T Magnetom Sonata scanner 
(Siemens Medical Systems, Erlangen, Germany). The DTI data were 
acquired with a single shot echo-planar imaging sequence acquired 
in the axial plane with six directions, b = 0 and 1000 mm2/s, 10 aver-
ages, TE = 97 ms, TR = 5400 ms, acquisition matrix = 192 × 192, 
FOV = 345 mm, voxel size = 1.8 × 1.8 × 3 mm3. Duration of acqui-
sition was 6.25 min.
DTI processing
The data were processed with the DTI module of Analyze software 
(BIR, Mayo Clinic, Rochester, MN, USA). Each DTI scan was ﬁ  rst 
binned into the baseline (b = 0) and six gradient encoded volumes 
(each containing 33 slices) using the Dicom Tool module and these 
seven separated scans were imported into the DTI module. After 
the diffusion gradient orientation information was entered for each 
volume, the data were thresholded to reduce extracerebral noise, the 
tensor was computed, and individual FA maps were generated.
Region of interest measurement
Images for manual tracing of regions of interest (ROIs) were dis-
played on a 21′ monitor and on a 21′ LCD digitizing tablet (Wacom 
Cintiq model 21UX; Wacom Inc., Vancouver, WA, USA) and mag-
niﬁ  ed ×2. Each ROI was traced manually with a stylus on the T2-
weighted (b = 0) baseline image for each participant in native space 
and supplemented with simultaneous side-by-side views from the 
FA and FA color map images in the same native coordinate space 
to maximize neuroanatomic validity. The saved ROI was applied to 
the FA maps and mean and standard deviation FA obtained within 
each ROI, for each participant separately on three slices, and then 
averaged across the three slices.
The ROIs were speciﬁ  cally drawn well within the inner portions 
of the WM regions to minimize the potential of partial volum-
ing effects that can occur in the border voxels at the interface of 
gray/white and CSF/white boundaries. Test–retest reliability was 
determined for one operator (Kristen M. Kennedy) by tracing eight 
images (for each ROI) on two separate occasions, 2 weeks apart. 
Reliability of mean FA for each ROI was assessed by an intrac-
lass correlation, formula ICC (3) (Shrout and Fleiss, 1979), and 
exceeded 0.90 (genu ICC3 = 0.91, splenium ICC3 = 0.99). The 
target ROIs, the genu and splenium of the corpus callosum, were 
demarcated as described below.
The operator drew a small ROI on the genu and the splenium 
(Figure 1), medially-to-laterally on the axial plane, with reference 
to the sagittal and coronal planes assisted by the OrthoReview func-
tion in Analyze ROI module. We took special care to exclude, both 
visually and by monitoring the standard deviations, pixels that 
could reﬂ  ect cerebro-spinal ﬂ  uid from the ventricles. The genu 
and the splenium were measured on the same three axial slices in 
which both were optimally visible.
STATISTICAL ANALYSES
The data were analyzed in the General Linear Model framework 
with SYSTAT 12 (Systat Software, Inc., Chicago, IL, USA). Age, 
centered at the sample mean, was a continuous predictor. Sex, 
hypertension status, and allelic variant of BDNF val66met (val 
vs. val/met) entered the model simultaneously as categorical pre-
dictors. The callosal ROI (genu and splenium) was the repeated 
measure, and FA was the dependent variable. Second-order interac-
tions among all predictors were also included in the models, but if 
found nonsigniﬁ  cant (p > 0.15) they were deleted from the model 
to conserve power. All interactions involving repeated measures 
used p-values adjusted by Huynh–Feldt correction factor.
RESULTS
The analysis revealed a signiﬁ   cant main effect of ROI [F(1, 
35) = 44.30, p < 0.0001], with splenium FA (0.79 ± 0.04) exceed-
ing that of the genu (0.74 ± 0.06), and a trend for the main effect of 
age F(1, 35) = 3.95, p = 0.055. None of the other between- subjects 
main effects reached signiﬁ  cance: sex F < 1 ns; hypertension F(1, 
35) = 1.16,  p = 0.29;  and  BDNF genotype F < 1 ns.  However, Frontiers in Human Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 19  |  4
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there was a signiﬁ  cant ROI × age × BDNF genotype interaction, 
F(1, 35) = 4.99, p = 0.03, indicating that the magnitude of the 
age differences in FA varied between the ROIs and depended on 
BDNF val66met genotype. The interactions age × BDNF genotype 
(F < 1), ROI × sex (F < 1), and ROI × hypertension (F < 1) were 
not signiﬁ  cant.
To decompose the ROI  × age × BDNF genotype interaction 
depicted in Figure 2, we regressed regional FA on age for each BDNF 
met allele group. In the BDNF val66 homozygotes (BDNF 66met-), 
there was a nonsigniﬁ  cant trend for an age effect in the genu FA 
(b = −0.00217 ± 0.00108; t = −2.02, r = −0.38, p = 0.055), and no 
age difference in splenium FA (b = −0.0004 ± 0.00063; t = 0.64, 
r = −0.13,  p  =  0.53). In heterozygotes (BDNF 66met carriers), 
there was also no age effect on genu FA: b = −0.00154 ± 0.00173, 
t = −0.90,  r = −0.24,  p = 0.39;  however,  a  signiﬁ  cant decline in 
splenium FA was observed: b = −0.00309 ± 0.00129,  t = −2.40, 
r = −0.55, p = 0.03. Removal of an outlier (74-year-old man) did 
not change the results for genu (t = −0.24, p = 0.81) or splenium 
(t = −2.43, p = 0.03). The contribution of nonlinear (quadratic) 
trends in all four regressions was not signiﬁ  cant. Comparison of 
age slopes of the four regression models revealed that all of the 
90% conﬁ  dence limits except one, overlapped. Only the slope of 
regression of the splenium FA among the val/val homozygotes was 
reliably ﬂ  atter than the rest.
DISCUSSION
The results of this small-scale investigation show that at least in one 
region, the splenium of the corpus callosum, age-related reduction 
in WM integrity depends on variation in a major neurotrophin 
gene. Only persons who carried a low-activity allele of the BDNF 
Val66Met polymorphism evidenced age-related decline in FA. 
Whereas the observed effects of age on the genu FA were unclear, 
the dependence of age-related differences in the splenium on BDNF 
genotype was apparent. Age had no effect on splenium FA in BDNF 
val66 homozygotes and was associated with a signiﬁ  cantly lower 
FA in the splenium of BDNF 66met carriers. There was a nonsig-
niﬁ  cant trend for the effect of age on the genu FA in the val group. 
However, examination of the correlations for each ROI and BDNF 
group suggests that for the genu FA, the strength of association was 
comparable between groups (r = −0.38 vs. −0.24) and the difference 
in signiﬁ  cance reﬂ  ects low statistical power of the study. In spite of 
that, this preliminary investigation is, to the best of our knowledge, 
the ﬁ  rst reported ﬁ  nding of BDNF val66met effect on regional WM 
integrity in healthy aging.
White matter aging is usually more prominent in the ante-
rior (prefrontal white and genu) than posterior (parietal white 
and splenium) brain regions (Raz et al., 2005, 2007; Sullivan and 
Pfefferbaum, 2006), whereas in the presence of pathological proc-
esses or risk factors, a more generalized pattern involving dete-
rioration of the posterior brain regions is observed as well (Raz 
et al., 2007). The ﬁ  nding reported here adds the low-activity BDNF 
met allele to the list of such risk factors. Further, these results are 
in accord with the report that the posterior region of the CC is 
under signiﬁ  cantly greater genetic control than anterior regions 
(Pfefferbaum et al., 2001).
Although investigation of relevant polymorphisms is an increas-
ingly popular means for explicating speciﬁ  c components of the 
observed genetic contribution to brain and cognition (de Geus et al., 
2008; Green et al., 2008; Mattay et al., 2008), association studies 
of speciﬁ  c polymorphisms and WM microstructure are still rare. 
The three extant studies report a negative inﬂ  uence of ApoE ε4 on 
parahippocampal (Nierenberg et al., 2005) and frontal (Bartzokis 
et al., 2006) WM and on the splenium (Persson et al., 2006) and genu 
(Bartzokis et al., 2006) in older adults. In young adults, neuroregu-
lin-1 has been found to affect FA in the internal capsule (McIntosh 
et al., 2008) and the medial frontal WM (Winterer et al., 2008). As 
mentioned, to date, no association studies examined the effects of 
BDNF genetic variation on cerebral WM in healthy adults.
Diffusion-derived indices of WM integrity reﬂ  ect many aspects 
and components of the WM structure (Song et al., 2002; Davis 
et al.,  2009), and they may be differentially affected by aging. 
Myelin is a product of metabolically intensive processes (Peters, 
2002; Bartzokis, 2004), and BDNF, in its capacity as a metabotropic 
factor and promoter of axonal growth, affects lifespan destiny of 
the WM. Thus far, BDNF has been implicated in repair and main-
tenance of the WM in demyelinating disease (Stadelmann et al., 
2002; Azoulay et al., 2008), although the role of BDNF val66met 
in that process is unclear (Weinstock-Guttman et al., 2007). The 
FIGURE 2 | The effects of BDNF 66met allele on age-related differences in 
fractional anisotropy of genu (upper panel) and splenium (lower panel) 
of the corpus callosum. Black solid line and circles correspond to val 
homozygotes; red broken line and triangles correspond to val/met 
heterozygotes.Frontiers in Human Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 19  |  5
Kennedy et al.  Age, BDNF , corpus callosum
  differential   vulnerability of the anterior and posterior portions of 
the   corpus callosum may stem from its cytological characteristics. 
Axon density, degree of myelination, and axonal diameter vary 
along the anterior-posterior axis of the corpus callosum (Lamantia 
and Rakic, 1990). The anterior portion is densely populated by 
small myelinated and unmyelinated axons, whereas the posterior 
portion contains a higher proportion of large myelinated axons 
and is the only segment to contain giant axons (i.e., 0.90 µm). The 
splenium also has the lowest percentage of unmyelinated axons 
(3.5%) in the corpus callosum (Lamantia and Rakic, 1990). Given 
this highly segregated organization, it stands to reason that the seg-
ments of the corpus callosum would be differentially sensitive to 
aging (Aboitiz et al., 1996) and to clinical and genetic risk factors. 
Because the splenium is the most heavily myelinated part of the 
corpus callosum, the impact of reduced capacity for axonal repair 
(e.g., due to dearth of BDNF) may be most apparent there.
Contrary to our hypothesis, we found neither a signiﬁ  cant effect 
of hypertension, nor a joint effect of that vascular risk factor and 
the genetic variation on WM integrity. The reasons for this are 
unclear, but may include relatively low statistical power as well 
as selection of healthier-than-average hypertensive individuals. In 
addition, this study is limited to a cross-sectional design and deri-
vation of the index of WM integrity from a relatively early version 
of the DTI sequence. Notably, the lack of signiﬁ  cant effects of age 
in the presence of nonsigniﬁ  cant trends in the expected direction 
can be attributed to the low statistical power and curtailment of 
age range to middle-aged and older adults. All these limitations are 
being addressed in the longitudinal study of a larger sample that is 
currently underway in our laboratory.
CONCLUSION
The positive effect of homozygosity for the high-activity BDNF val 
allele on a selected region of the cerebral WM, the splenium of the 
corpus callosum, suggests that with adequate BDNF availability 
older adults may beneﬁ  t from the plasticity and repair mechanisms 
to maintain healthy aging, whereas carriers of the met allele may 
be at risk for more widespread WM deterioration. Maintenance of 
these repair mechanisms in the posterior corpus callosum in older 
age may be important for the preservation of cognitive functions 
dependent on interhemispheric transfer via this region – spatial, 
mnemonic, and visual processing.
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